Frequently Asked Questions
The market is segmented based on , By Product (CPET Systems, Metabolic Carts, ECG and EKG Systems, Body Composition Analyzers, and Software), Application (Lifestyle Diseases, Critical Care, Human Performance Testing, Dysmetabolic Syndrome X, and Metabolic Disorders), Technology (VO2 Max Analysis, RMR Analysis, and Body Composition Analysis), End User (Hospitals, Laboratories, Sports Training Centers, and Gyms) - Industry Trends and Forecast to 2031.
.
The Global Metabolic Testing Market size was valued at USD 672.72 USD Million in 2023.
The Global Metabolic Testing Market is projected to grow at a CAGR of 7.95% during the forecast period of 2024 to 2031.
The major players operating in the market include KORR Medical Technologies (U.S.), GE HealthCare (U.S.), Geratherm Medical AG (Germany), MGC DIAGNOSTICS CORPORATION (U.S.), AEI Technologies, Inc. (U.S.), COSMED srl (Italy), Microlife Medical Home Solutions (Switzerland), Parvo Medics (U.S.), CORTEX Biophysik GmbH (Germany), VacuMed (U.S.), Abbott (U.S.), Promega Corporation (U.S.), VYAIRE (U.S.), Koninklijke Philips N.V. (Netherlands).
The market report covers data from the U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America.
